Infectious Diseases and Critical Care
Clinical research in sepsis and antimicrobial therapy includes interest in linezolid treatment optimization, with attention to safety outcomes such as thrombocytopenia in acutely ill patients.
- Sepsis
- Linezolid
- Pharmacokinetics and pharmacodynamics
- Thrombocytopenia
This area also includes studies relevant to hospital-based management of severe infection and treatment individualization in critical care.
Rare Metabolic and Nutritional Disorders
The sponsor supports research in inherited metabolic conditions such as hydroxycobalamin deficiency, metilcrotonilglicinuria, and biotinidase deficiency, with a focus on improving therapeutic tolerability and access to suitable formulations for pediatric care.
- Hydroxycobalamin
- Biotin
- Inborn errors of metabolism
- Pediatric rare disease care
Research in this domain reflects interest in supportive treatment strategies for children with rare hereditary metabolic disease.
Cardiology and Cardiac Rhythm Disorders
Studies in idiopathic ventricular arrhythmias examine comparative treatment approaches aimed at reducing ventricular ectopy and improving rhythm control in patients with cardiac arrhythmia.
- Idiopathic ventricular arrhythmias
- Holter-ECG
- Antiarrhythmic therapy
- Ventricular ectopy
This research area is centered on outpatient cardiology and the evaluation of symptomatic rhythm disturbances.
Oncology and Pancreatic Disease
Clinical trials in breast cancer and pancreatic cancer cover tumour assessment and supportive care, including pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy to address nutritional compromise in advanced disease.
- Breast cancer
- Pancreatic cancer
- Pancreatic exocrine insufficiency
- Nutritional status
Research interest extends to imaging-based evaluation of tumour behaviour and symptom-focused care in oncology.
Respiratory Health and Tobacco Cessation
The sponsor is active in studies of respiratory diseases, including antiviral activity against COVID-19, influenza A, and RSV, alongside research supporting smoking cessation in active smokers.
- Respiratory viruses
- Oral antiseptics
- Smoking cessation
- Cytisinicline
These studies reflect interest in respiratory infection control and behavioural interventions for tobacco dependence.
